Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ DeFi Development Corp. to Ring the Nasdaq Closing Bell This Friday, Celebrating Milestones and the... (GlobeNewswire EN) +++ DEFI DEVELOPMENT Aktie +4,64%

INSPIRE MEDICAL Aktie

 >INSPIRE MEDICAL Aktienkurs 
76.2 EUR    -3.3%    (Tradegate)
Ask: 77.16 EUR / 160 Stück
Bid: 75.3 EUR / 160 Stück
Tagesumsatz: 37 Stück
Realtime Kurs von 8 bis 22 Uhr!
Aktie über LYNX handeln
>INSPIRE MEDICAL Performance
1 Woche: +1,8%
1 Monat: -28,3%
3 Monate: -38,1%
6 Monate: -58,0%
1 Jahr: -53,4%
laufendes Jahr: -56,3%
>INSPIRE MEDICAL Aktie
Name:  INSPIRE MEDICAL SYSTEMS
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4577301090 / A2JLEP
Symbol/ Ticker:  2DR (Frankfurt) / INSP (NYSE)
Kürzel:  FRA:2DR, ETR:2DR, 2DR:GR, NYSE:INSP
Index:  -
Webseite:  https://www.inspiresleep...
Profil:  Inspire Medical Systems, Inc. is a pioneering comp..
>Volltext..
Marktkapitalisierung:  2342.89 Mio. EUR
Unternehmenswert:  2114.31 Mio. EUR
Umsatz:  743.69 Mio. EUR
EBITDA:  45.06 Mio. EUR
Nettogewinn:  45.87 Mio. EUR
Gewinn je Aktie:  1.54 EUR
Schulden:  28.54 Mio. EUR
Liquide Mittel:  92.32 Mio. EUR
Operativer Cashflow:  101.41 Mio. EUR
Bargeldquote:  3.22
Umsatzwachstum:  10.98%
Gewinnwachstum:  703.56%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  INSPIRE MEDICAL
Letzte Datenerhebung:  27.08.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 29.57 Mio. St.
Frei handelbar: 90.26%
Rückkaufquote: 4.53%
Mitarbeiter: 1246
Umsatz/Mitarb.: 0.56 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 63.16%
Bewertung:
KGV: 52.49
KGV lG: 86.73
KUV: 3.15
KBV: 3.95
PEG-Ratio: 0.06
EV/EBITDA: 46.92
Rentabilität:
Bruttomarge: 84.47%
Gewinnmarge: 6.17%
Operative Marge: 4.81%
Managementeffizenz:
Gesamtkaprendite: 6.94%
Eigenkaprendite: 8.07%
>Peer Group

Es sind 601 Aktien bekannt.
 
26.08.25 - 23:06
Inspire Medical reaffirms updated 2025 guidance (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.25 - 22:39
Inspire Medical Systems CFO departs (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.25 - 22:33
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer (GlobeNewswire EN)
 
MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its Chief Financial Officer, Rick Buchholz, will be stepping down from his current position with the Company, effective December 31, 2025, in order to pursue other professional opportunities. Buchholz will remain employed with the Company in a financial advisory role through February 28, 2026, to ensure a smooth transition....
22.08.25 - 16:00
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock? (Zacks)
 
Investors need to pay close attention to INSP stock based on the movements in the options market lately....
20.08.25 - 14:03
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference (GlobeNewswire EN)
 
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025....
16.08.25 - 16:06
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP (PR Newswire)
 
NEW YORK, Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
15.08.25 - 21:48
13 Analysts Have This To Say About Inspire Medical Systems (Benzinga)
 
Latest Ratings for INSP DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Piper SandlerMaintainsOverweight Nov 2021Wells FargoMaintainsOverweight View More Analyst Ratings for INSP View the Latest Analyst Ratings read more...
12.08.25 - 15:18
INSP Investors Have Opportunity to Join Inspire Medical Systems, Inc. Fraud Investigation with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, Aug. 12, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or "the Company") (NYSE: INSP) for violations of the securities laws.......
11.08.25 - 23:01
US Extends China Truce, Open to Scaled-Back Blackwell Sales | Bloomberg Businessweek Daily 8/11/2025 (Bloomberg)
 
On today's episode of Bloomberg Businessweek Daily, Tim Stenovec and Isabelle Lee speak with Jordan Klein, Managing Director at Mizuho Securities USA on the signal from President Trump that he would be open to allowing Nvidia Corp. to sell a scaled-back version of its most advanced AI chip to China. They also spoke with Senior Non-Resident Fellow at New York University Ed Price on Trump's extension of the 90 day trade truce with China, and upcoming summit with Russian President Vladimir Putin. Finally, Tim Herbert, president and CEO of Inspire Medical System, discussed his company's earnings and share buyback announcement. (Source: Bloomberg)...
11.08.25 - 16:01
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP (PR Newswire)
 
NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
11.08.25 - 15:18
Inspire Medical to effect up to $200M stock buyback program (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
11.08.25 - 14:03
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program (GlobeNewswire EN)
 
MINNEAPOLIS, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that its Board of Directors has authorized the repurchase of up to $200 million of the company's outstanding shares of common stock....
07.08.25 - 19:30
Inspire Medical Stock Strays Off Course Amid Structural Setback (Benzinga)
 
Inspire Medical's chart structure signals weakness after a major breakdown. Here's why investors may want to avoid the stock until 2028. read more...
05.08.25 - 20:57
Inspire Medical Systems Analysts Lower Their Forecasts After Q2 Results (Benzinga)
 
Latest Ratings for INSP DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Piper SandlerMaintainsOverweight Nov 2021Wells FargoMaintainsOverweight View More Analyst Ratings for INSP View the Latest Analyst Ratings read more...
05.08.25 - 19:00
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts (Zacks)
 
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure....
05.08.25 - 15:15
JPM downgrades Inspire Medical on lowered guidance (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 14:48
Pre-market Movers: Arteris, STAAR Surgical, Ichor Holdings, Inspire Medical Systems, Castle Biosciences (AFX)
 
CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.15 A.M. ET).In the Green Arteris, Inc. (AIP) is up over 61% at......
05.08.25 - 14:00
Inspire Medical (INSP) Q2 Revenue Up 11% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 05:30
Inspire Medical Systems cuts 2025 revenue guidance to $900M-$910M amid Inspire V rollout delays (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wo es schon längere Zeit nicht gehagelt hat, läßt sich schon eine Hagelversicherung kaum verkaufen. - Komm.-Rat DDr. Norbert Zimmer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!